{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "70264-014",
      "generic_name": "ANHYDROUS CITRIC ACID, ASPIRIN, and SODIUM BICARBONATE",
      "labeler_name": "R J General Corporation",
      "brand_name": "Alka-Seltzer Original",
      "active_ingredients": [
        {
          "name": "ASPIRIN",
          "strength": "325 mg/1"
        },
        {
          "name": "SODIUM BICARBONATE",
          "strength": "1916 mg/1"
        },
        {
          "name": "ANHYDROUS CITRIC ACID",
          "strength": "1000 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "70264-014-01",
          "description": "50 POUCH in 1 CARTON (70264-014-01)  / 2 TABLET, EFFERVESCENT in 1 POUCH",
          "marketing_start_date": "20100302",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "R J General Corporation"
        ],
        "rxcui": [
          "1536675",
          "1536680"
        ],
        "spl_set_id": [
          "dbb0d067-71f0-45e4-bc98-548cf4a90b3a"
        ],
        "upc": [
          "0026431297031"
        ],
        "nui": [
          "N0000000160",
          "N0000008836",
          "M0001335",
          "N0000175722",
          "N0000175578",
          "N0000008832",
          "N0000175833",
          "N0000175835",
          "N0000175980",
          "N0000008556",
          "N0000175089"
        ],
        "pharm_class_moa": [
          "Cyclooxygenase Inhibitors [MoA]",
          "Acidifying Activity [MoA]",
          "Calcium Chelating Activity [MoA]"
        ],
        "pharm_class_pe": [
          "Decreased Prostaglandin Production [PE]",
          "Decreased Platelet Aggregation [PE]",
          "Decreased Coagulation Factor Activity [PE]"
        ],
        "pharm_class_cs": [
          "Anti-Inflammatory Agents, Non-Steroidal [CS]"
        ],
        "pharm_class_epc": [
          "Nonsteroidal Anti-inflammatory Drug [EPC]",
          "Platelet Aggregation Inhibitor [EPC]",
          "Calculi Dissolution Agent [EPC]",
          "Anti-coagulant [EPC]"
        ],
        "unii": [
          "R16CO5Y76E",
          "8MDF5V39QO",
          "XF417D3PSL"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "TABLET, EFFERVESCENT",
      "spl_id": "43c89573-4cf2-997f-e063-6394a90a76ca",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20100302",
      "product_id": "70264-014_43c89573-4cf2-997f-e063-6394a90a76ca",
      "application_number": "M013",
      "brand_name_base": "Alka-Seltzer Original",
      "pharm_class": [
        "Acidifying Activity [MoA]",
        "Alkalinizing Activity [MoA]",
        "Anti-Inflammatory Agents",
        "Non-Steroidal [CS]",
        "Anti-coagulant [EPC]",
        "Calcium Chelating Activity [MoA]",
        "Calculi Dissolution Agent [EPC]",
        "Cyclooxygenase Inhibitors [MoA]",
        "Decreased Coagulation Factor Activity [PE]",
        "Decreased Platelet Aggregation [PE]",
        "Decreased Prostaglandin Production [PE]",
        "Nonsteroidal Anti-inflammatory Drug [EPC]",
        "Platelet Aggregation Inhibitor [EPC]"
      ]
    }
  ]
}